These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37580158)

  • 1. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes.
    Boon BDC; Labuzan SA; Peng Z; Matchett BJ; Kouri N; Hinkle KM; Lachner C; Ross OA; Ertekin-Taner N; Carter RE; Ferman TJ; Duara R; Dickson DW; Graff-Radford NR; Murray ME
    Neurology; 2023 Oct; 101(14):e1412-e1423. PubMed ID: 37580158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
    Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW
    Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
    Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA
    Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.
    Hanna Al-Shaikh FS; Duara R; Crook JE; Lesser ER; Schaeverbeke J; Hinkle KM; Ross OA; Ertekin-Taner N; Pedraza O; Dickson DW; Graff-Radford NR; Murray ME
    JAMA Neurol; 2020 Feb; 77(2):225-233. PubMed ID: 31657834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease.
    Kouri N; Frankenhauser I; Peng Z; Labuzan SA; Boon BDC; Moloney CM; Pottier C; Wickland DP; Caetano-Anolles K; Corriveau-Lecavalier N; Tranovich JF; Wood AC; Hinkle KM; Lincoln SJ; Spychalla AJ; Senjem ML; Przybelski SA; Engelberg-Cook E; Schwarz CG; Kwan RS; Lesser ER; Crook JE; Carter RE; Ross OA; Lachner C; Ertekin-Taner N; Ferman TJ; Fields JA; Machulda MM; Ramanan VK; Nguyen AT; Reichard RR; Jones DT; Graff-Radford J; Boeve BF; Knopman DS; Petersen RC; Jack CR; Kantarci K; Day GS; Duara R; Graff-Radford NR; Dickson DW; Lowe VJ; Vemuri P; Murray ME
    JAMA Neurol; 2024 Jun; 81(6):619-629. PubMed ID: 38619853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
    Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME
    Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
    Mohanty R; Ferreira D; Frerich S; Muehlboeck JS; Grothe MJ; Westman E;
    Neurology; 2022 Jul; 99(4):e323-e333. PubMed ID: 35609990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse limbic comorbidities cause limbic and temporal atrophy in lewy body disease.
    Sakurai K; Kaneda D; Morimoto S; Uchida Y; Inui S; Kimura Y; Cai C; Kato T; Ito K; Hashizume Y
    Parkinsonism Relat Disord; 2022 Dec; 105():52-57. PubMed ID: 36368094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.
    Nedelska Z; Ferman TJ; Boeve BF; Przybelski SA; Lesnick TG; Murray ME; Gunter JL; Senjem ML; Vemuri P; Smith GE; Geda YE; Graff-Radford J; Knopman DS; Petersen RC; Parisi JE; Dickson DW; Jack CR; Kantarci K
    Neurobiol Aging; 2015 Jan; 36(1):452-61. PubMed ID: 25128280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.
    Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW
    Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review.
    Ferreira D; Mohanty R; Murray ME; Nordberg A; Kantarci K; Westman E
    Acta Neuropathol Commun; 2022 Nov; 10(1):166. PubMed ID: 36376963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease.
    Ferman TJ; Arvanitakis Z; Fujishiro H; Duara R; Parfitt F; Purdy M; Waters C; Barker W; Graff-Radford NR; Dickson DW
    Parkinsonism Relat Disord; 2013 Feb; 19(2):227-31. PubMed ID: 23182311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Lewy Pathology on Alzheimer's Disease Phenotype: A Retrospective Clinico-Pathological Study.
    Roudil J; Deramecourt V; Dufournet B; Dubois B; Ceccaldi M; Duyckaerts C; Pasquier F; Lebouvier T;
    J Alzheimers Dis; 2018; 63(4):1317-1323. PubMed ID: 29758938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP717 gene mutation.
    Rosenberg CK; Pericak-Vance MA; Saunders AM; Gilbert JR; Gaskell PC; Hulette CM
    Acta Neuropathol; 2000 Aug; 100(2):145-52. PubMed ID: 10963361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies.
    Merdes AR; Hansen LA; Jeste DV; Galasko D; Hofstetter CR; Ho GJ; Thal LJ; Corey-Bloom J
    Neurology; 2003 May; 60(10):1586-90. PubMed ID: 12771246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
    Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
    Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex and age interact to determine clinicopathologic differences in Alzheimer's disease.
    Liesinger AM; Graff-Radford NR; Duara R; Carter RE; Hanna Al-Shaikh FS; Koga S; Hinkle KM; DiLello SK; Johnson MF; Aziz A; Ertekin-Taner N; Ross OA; Dickson DW; Murray ME
    Acta Neuropathol; 2018 Dec; 136(6):873-885. PubMed ID: 30219939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.